New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New surgical method for ovarian cancer lights up lesions

New surgical method for ovarian cancer lights up lesions

by Joel Streed,Mayo ClinicCredit: Mayo ClinicMayo Clinic scientists are shining light on ovarian cancer. Astudypublished in 2022 in theJournal of Clinical Oncologyexplore
World medicine December 12,2023
New surgical method for ovarian cancer lights up lesions

New surgical method for ovarian cancer lights up lesions

by Joel Streed,Mayo ClinicCredit: Mayo ClinicMayo Clinic scientists are shining light on ovarian cancer. Astudypublished in 2022 in theJournal of Clinical Oncologyexplore
World medicine December 12,2023
Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

byQueen Mary, University of LondonHD MAMs have a reduced phagocytic response and alter T cell activation in the presence of CD3 and CD28 stimulation. MAMs were cultured for 14 days and K562 cell
World medicine December 12,2023
Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

Ovarian cancer's protective barrier: How the tumor matrix teaches cells to disarm immune attack

byQueen Mary, University of LondonHD MAMs have a reduced phagocytic response and alter T cell activation in the presence of CD3 and CD28 stimulation. MAMs were cultured for 14 days and K562 cell
World medicine December 12,2023
Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

by Society of Nuclear Medicine and Molecular ImagingCredit: Pixabay/CC0 Public DomainThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and 10 other professional societies have issued new a
World medicine December 12,2023
Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

Appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema

by Society of Nuclear Medicine and Molecular ImagingCredit: Pixabay/CC0 Public DomainThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and 10 other professional societies have issued new a
World medicine December 12,2023
Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

byMcGill University Health CentreCredit: Pixabay/CC0 Public DomainTogether, the McGill University Health Centre (MUHC), the Centre hospitalier de l'Université de Montréal (CHUM) and St. Mary
World medicine December 12,2023
Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

Clinical trial confirms immunotherapy drug's efficiency for treating lung cancer

byMcGill University Health CentreCredit: Pixabay/CC0 Public DomainTogether, the McGill University Health Centre (MUHC), the Centre hospitalier de l'Université de Montréal (CHUM) and St. Mary
World medicine December 12,2023
Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is
World medicine December 12,2023
Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

Clinical trial: Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is
World medicine December 12,2023
Clinical trial shows tumor-starving drug improves survival of mesothelioma

Clinical trial shows tumor-starving drug improves survival of mesothelioma

byQueen Mary, University of LondonPeter Szlosarek. Credit: Queen Mary, University of LondonPeter Szlosarek, Professor of Medical Oncology at Queen Mary's Barts Cancer Institute, presented hi
World medicine December 12,2023
Clinical trial shows tumor-starving drug improves survival of mesothelioma

Clinical trial shows tumor-starving drug improves survival of mesothelioma

byQueen Mary, University of LondonPeter Szlosarek. Credit: Queen Mary, University of LondonPeter Szlosarek, Professor of Medical Oncology at Queen Mary's Barts Cancer Institute, presented hi
World medicine December 12,2023
Clinical trial shows promising results for patients with advanced neuroendocrine tumors

Clinical trial shows promising results for patients with advanced neuroendocrine tumors

by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainThe Alliance for Clinical Trials in Oncology today announced that an independent Data and Safety Monitoring Board (DSMB) det
World medicine December 12,2023
Clinical trial shows promising results for patients with advanced neuroendocrine tumors

Clinical trial shows promising results for patients with advanced neuroendocrine tumors

by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainThe Alliance for Clinical Trials in Oncology today announced that an independent Data and Safety Monitoring Board (DSMB) det
World medicine December 12,2023
Clinical trial: Three-drug combination slows progression of advanced kidney cancer

Clinical trial: Three-drug combination slows progression of advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previ
World medicine December 12,2023
Clinical trial: Three-drug combination slows progression of advanced kidney cancer

Clinical trial: Three-drug combination slows progression of advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previ
World medicine December 12,2023
Clinical trial: Immunotherapy strongly improves prognosis of babies with leukemia

Clinical trial: Immunotherapy strongly improves prognosis of babies with leukemia

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainImmunotherapy with blinatumomab leads to a strongly improved survival rate—from 66% to 93%—for children with an aggres
World medicine December 12,2023
Clinical trial: Immunotherapy strongly improves prognosis of babies with leukemia

Clinical trial: Immunotherapy strongly improves prognosis of babies with leukemia

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainImmunotherapy with blinatumomab leads to a strongly improved survival rate—from 66% to 93%—for children with an aggres
World medicine December 12,2023
Clinical trial: Combination treatment extends progression-free survival in brain cancer

Clinical trial: Combination treatment extends progression-free survival in brain cancer

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainRepeat radiation therapy combined with the monoclonal antibody drug bevacizumab extended progression-free survival in pa
World medicine December 12,2023
Clinical trial: Combination treatment extends progression-free survival in brain cancer

Clinical trial: Combination treatment extends progression-free survival in brain cancer

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainRepeat radiation therapy combined with the monoclonal antibody drug bevacizumab extended progression-free survival in pa
World medicine December 12,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com